Chemours sues DuPont; a subsidiary suing its parent company triggers a cascade of scandals!

Court documents state that DuPont 'orchestrated the spin-off of its Performance Chemicals Unit to form a new company named Chemours as part of a plan to mitigate its historical environmental liabilities.' These documents were filed in Delaware courts and were originally intended to remain confidential. However, when Chemours’ attorneys failed to submit a public version by the court’s deadline, the Associated Press petitioned the Delaware Supreme Court to unseal the documents—without redaction. The documents state that in 2010, DuPont commissioned 'a blue-ribbon panel composed of company managers, scientists, and engineers to devise a solution to this widely acknowledged problem.' The company could have spent $60 million to completely halt emissions—or just $20 million to reduce them by 70%. 'But even the mildest recommended solution was too much for DuPont,' the court documents state. Instead, after installing a $2.3 million system that eliminated one wastewater stream, DuPont decided to shut down that system by the end of 2013. Coincidentally, it was precisely at that time that DuPont announced its plan to spin off Chemours—a project internally codenamed 'Project Beta.' Project Beta focused on DuPont’s Performance Chemicals Unit—the very division responsible for 'many of DuPont’s environmental liabilities,' including those related to PFAS such as GenX. The documents state: 'Since this problem could be conveniently transferred to Chemours, why spend money solving it?' And that is exactly what happened. This year, Chemours, the North Carolina Department of Environmental Quality, and Cape Fear River Watch signed a consent order imposing a $12 million penalty on Chemours. The order requires Chemours to 'adopt the same technology DuPont previously refused to install.' When DuPont established Chemours as a subsidiary in spring 2015, it knew the Fayetteville plant had been discharging PFAS into the Cape Fear River for over 30 years. Yet, in private corporate discussions, DuPont assured Chemours that cleaning up the Fayetteville site would cost no more than $2 million. That figure is now estimated at $200 million—not including potential penalties from class-action lawsuits. Moreover, Chemours must also spend hundreds of millions of dollars to remediate several sites in New Jersey. DuPont also 'shockingly' underestimated the cost of resolving roughly 3,500 lawsuits—filed by residents near DuPont’s Washington Works plant in Ohio/West Virginia, whose drinking water had been contaminated with PFAS discharged from the production line. 'These are serious cases. Hundreds of plaintiffs have cancer; others suffer from other severe illnesses.' DuPont engaged Deloitte to analyze potential litigation costs; Deloitte estimated DuPont would win 68% of the cases. 'The remaining cases could be resolved relatively cheaply'—at $128 million, including defense attorney fees.

In-depth analysis of the refrigerant industry: policy environment, supply-demand dynamics, competitive landscape, industrial chain, and key companies (produced by Huibo Research)

The upward momentum in the third-generation refrigerant sector remains intact, and the company stands to benefit substantially. Since the implementation of the production quota system in 2024, HFCs—functioning as essential functional agents and 'must-have consumer goods'—have gradually adopted a global 'franchise-style' business model. As a result, product prices have continued recovering, gross margins have surged significantly, and the upward pricing trend is expected to persist through 2026. According to Baichuan Intelligence data, as of August 26, 2026, domestic market average prices for the company’s core third-generation refrigerants—R32, R125, and R134a—stood at RMB 64,500/ton, RMB 55,000/ton, and RMB 64,500/ton, respectively—up 2.38%, 14.58%, and 11.21% from the beginning of the year. Looking ahead, in the absence of disruptive technological innovation in the third-generation refrigerant sector and under stable operation of the quota policy, price increases for mainstream third-generation refrigerants are highly certain—and their upside potential remains substantial. Consequently, the company’s profit center is expected to rise steadily, driven by rising third-generation refrigerant prices. 2. Sanmei Co., Ltd. Average refrigerant prices continue climbing, and the company’s first-half performance grew year-on-year. Driven by supply-side constraints and resilient demand, the refrigerant industry’s competitive landscape continues optimizing, and the price floor for mainstream refrigerants is rising. Recently, the company’s fluorinated refrigerant prices surged year-on-year, lifting both revenue and gross margin—and enhancing profitability steadily. According to the company’s announcement, in H1 2026, the average selling price and external sales volume of the company’s fluorinated refrigerants were RMB 48,000/ton and 60,600 tons, respectively—up 22.1% and down 2.2% year-on-year. The upward momentum in the third-generation refrigerant sector remains intact, and the company stands to benefit substantially. In 2026, the fluorinated refrigerant industry’s quota management policy remains in effect: production quotas for second-generation fluorinated refrigerants (HCFCs) are further reduced, while overall quotas for third-generation fluorinated refrigerants (HFCs) remain stable. Under the combined influence of supply-side constraints and resilient demand, industry supply-demand balance is improving and competitive order continues strengthening—pushing the price floor for mainstream refrigerants higher. According to Baichuan Intelligence data, as of August 26, 2026, domestic market average prices for the company’s core third-generation refrigerants—R32, R125, and R134a—stood at RMB 64,500/ton, RMB 55,000/ton, and RMB 64,500/ton, respectively—up 2.38%, 14.58%, and 11.21% from the beginning of the year. Looking ahead, in the absence of disruptive technological innovation in the third-generation refrigerant sector and under stable operation of the quota policy, price increases for mainstream third-generation refrigerants are highly certain—and their upside potential remains substantial. Consequently, the company’s profit center is expected to rise steadily, driven by rising third-generation refrigerant prices. Multiple projects advancing steadily, deepening integrated industrial chain layout. Building upon its traditional business advantages, the company continues deepening vertical integration across the upstream and downstream industrial chain, steadily advancing key construction projects, and ensuring effective implementation of strategic plans. To date, Zhejiang Sanmei’s 5,000-ton-per-year polytetrafluoroethylene (FEP), catalyst project; Chongqing Jialihuo’s integrated fluorochemical project (Phase I)—including its commissioned 200,000-ton-per-year caustic soda capacity, chloromethane, and tetrachloroethylene retrofit project—have all entered trial production. Fujian Dongying’s commissioned 1,500-ton-per-year lithium hexafluorophosphate production capacity is currently undergoing technical upgrades.

Chemours Faces Class Action Over Refrigerant Demand Overstatement and Stock Decline

Oct 15, 2026

Chemours faces a securities class action lawsuit alleging failure to disclose oversupply in the refrigerant aftermarket, leading to an 18% stock decline and reduced EBITDA guidance. Investors purchasing shares between February and August 2026 may file lead plaintiff applications.

FinancialContent

2026-10-09

Chemours Company Faces Securities Fraud Class Action Over Opteon Demand Claims

2026-10-11

Chemours Faces Securities Lawsuit Over Disclosures and Guidance

2026-10-11

Chemours Company Faces Class Action Lawsuit Alleging Investor Harm

2026-10-12

Class Action Lawsuit Filed Against Chemours for Misleading Investors on Product Demand and Financial Guidance.

2026-10-12

Class Action Lawsuit Filed Against Chemours Over Overstated Demand and Lowered 2026 Guidance